(Q45752583)
Statements
Recombinant CD40L treatment protects allogeneic murine bone marrow transplant recipients from death caused by herpes simplex virus-1 infection (English)
Beland JL
Adler H
Del-Pan NC
Kozlow W
Sung J
Fanslow W
1 December 1998